Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia -: Evaluation of outcome

被引:207
作者
Ruiz, M
Torres, A
Ewig, S
Marcos, MA
Alcón, A
Lledó, R
Asenjo, MA
Maldonaldo, A
机构
[1] Hosp Clin Barcelona, Serv Pneumol & Allergia Resp, Direccio Tecm, Barcelona 08036, Spain
[2] Hosp Clin Barcelona, Microbiol Serv, Direccio Tecm, Barcelona 08036, Spain
[3] Hosp Clin Barcelona, Anesthesiol Serv, Direccio Tecm, Barcelona 08036, Spain
关键词
D O I
10.1164/ajrccm.162.1.9907090
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Noninvasive and invasive diagnostic techniques have been shown to achieve comparable performances in the evaluation of suspected ventilator-associated pneumonia (VAP). We studied the impact of both approaches on outcome in a prospective, open, and randomized study in three intensive care units (ICUs) of a 1,000-bed tertiary care university hospital. Patients with suspected VAP were randomly assigned to noninvasive (Group 1) versus invasive (Croup 2) investigation (tracheobronchial aspirates [TBAS] versus bronchoscopically retrieved protected specimen brush [PSB] and bronchoalveolar lavage [BAL]. Samples were cultured quantitatively, and BAL fluid (BALF) was examined for intracellular organisms (ICO) additionally. Initial empiric antimicrobial treatment was administered following the guidelines of the American Thoracic Society (ATS) and adjusted according to culture results land ICO counts in Group 2). Outcome variables included length of ICU stay and mechanical ventilation as well as mortality. Overall, 76 patients (39 noninvasive, 37 invasive) were investigated. VAP was microbiologically confirmed in 23 of 39 (59%) and 23 of 37 (62%) (p = 0.78). There were no differences with regard to the frequencies of community-acquired and potentially drug-resistant microorganisms (PDRM). Antimicrobial treatment was changed in seven patients (18%) of Group 1 and 10 patients (27%) of Group 2 because of etiologic findings (including five of 17 with ICO = 2% (p = not significant [NS]). Length of ICU stay and mechanical ventilation were also not significantly different in both groups. Crude 30-d mortality was 31 of 76 (41%), and 18 of 39 (46%) in Group 1 and 14 of 37 (38%) in Group 2 (p = 0.46). Adjusted mortality was 16% versus 11% (p = 0.53), and mortality of microbiologically confirmed pneumonia 10 of 23 (44%) in both groups (p = 1.0). We conclude that the outcome of VAP was not influenced by the techniques used for microbial investigation.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 37 条
[31]   Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: Impact of previous antimicrobial treatments [J].
Souweine, B ;
Veber, B ;
Bedos, JP ;
Gachot, B ;
Dombret, MC ;
Regnier, B ;
Wolff, M .
CRITICAL CARE MEDICINE, 1998, 26 (02) :236-244
[32]   Diagnosis and treatment of ventilator-associated pneumonia - Impact on survival - A decision analysis [J].
Sterling, TR ;
Ho, EJ ;
Brehm, WT ;
Kirkpatrick, MB .
CHEST, 1996, 110 (04) :1025-1034
[33]   Mortality of nosocomial pneumonia in ventilated patients: Influence of diagnostic tools [J].
Timsit, JF ;
Chevret, S ;
Valcke, J ;
Misset, B ;
Renaud, B ;
Goldstein, FW ;
Vaury, P ;
Carlet, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (01) :116-123
[34]   VALIDATION OF DIFFERENT TECHNIQUES FOR THE DIAGNOSIS OF VENTILATOR-ASSOCIATED PNEUMONIA - COMPARISON WITH IMMEDIATE POSTMORTEM PULMONARY BIOPSY [J].
TORRES, A ;
ELEBIARY, M ;
PADRO, L ;
GONZALEZ, J ;
DELABELLACASA, JP ;
RAMIREZ, J ;
XAUBET, A ;
FERRER, M ;
RODRIGUEZROISIN, R .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (02) :324-331
[35]   INCIDENCE, RISK, AND PROGNOSIS FACTORS OF NOSOCOMIAL PNEUMONIA IN MECHANICALLY VENTILATED PATIENTS [J].
TORRES, A ;
AZNAR, R ;
GATELL, JM ;
JIMENEZ, P ;
GONZALEZ, J ;
FERRER, A ;
CELIS, R ;
RODRIGUEZROISIN, R .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (03) :523-528
[36]   Diagnostic approaches and hospital-acquired pneumonia [J].
Torres, A ;
ElEbiary, M .
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 18 (02) :149-161
[37]  
Wunderink RG, 1998, AM J RESP CRIT CARE, V157, P349